Loading…
Congenital Heart Futures Reauthorization Act of 2017
Legislative Progress
Introduced
February 27, 2017
Latest Action
December 21, 2018
Primary Sponsor
Gus M. BilirakisRepublican(FL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
100pct
662d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Congenital Heart Futures Reauthorization Act of 2017 (Sec. 2) This bill amends the Public Health Service Act to replace the authorization for a National Congenital Heart Disease Surveillance System with a requirement for the Department of Health and Human Services (HHS) to enhance and expand congenital heart disease research, surveillance, and awareness. (Congenital heart disease is a condition caused by a heart defect that is present at birth.) HHS must award grants to nonprofit entities to conduct a study of congenital heart disease among all ages, including prevalence, health care utilization, and demographic factors. Collected information must be made available to the public. (Sec. 3) HHS must report on research and other activities conducted regarding congenital heart disease.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2018 · fourth_quarter · Health Issues
Became Public Law No: 115-342.
Became Public Law No: 115-342.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Motion to reconsider laid on the table Agreed to without objection.
On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 355 - 7 (Roll no. 436). (text: CR H10278)
HouseResolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 355 - 7 (Roll no. 436).(text: CR H10278)
HouseAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) H.Res 827- Expressing Support for designation of April 2018 as "National Donate Life Month" Health equity and accountability Act of 2018(no bill # introduced 5/23) H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) Regulatory Accountability Act(S.951) S.3388- Ensuring Coverage for Patients with Pre-Existing Conditions Act S.Res479- A resolution designating April 2018 as "National Donate Life Month" Short Term CRA (S.J. Res.63)
Client expense: $168,587 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · fourth_quarter · Health Issues
Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, including H.R. 5385, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; medical isotope production and supply; digital health/FDA pre-certification; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness.
Client expense: $480,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2018 · fourth_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, EHR data blocking, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, registry access to Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills, tobacco regulation in the FDA, Evaluation and Management coding collapse, price transparency, ECMO coding
Client expense: $84,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
2018 · fourth_quarter · Health Issues
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Health Issues
Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, including H.R. 5385, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; medical isotope production and supply; digital health/FDA pre-certification; cardiomyopathy education and awareness.
Client expense: $750,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2018 · third_quarter · Health Issues
Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) H.Res 827- Expressing Support for designation of April 2018 as "National Donate Life Month" Health equity and accountability Act of 2018(no bill # introduced 5/23) H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) Regulatory Accountability Act(S.951) S.3388- Ensuring Coverage for Patients with Pre-Existing Conditions Act S.Res479- A resolution designating April 2018 as "National Donate Life Month"
Client expense: $110,535 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · third_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, EHR data blocking, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, registry access to Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills, tobacco regulation in the FDA, Evaluation and Management coding collapse, price transparency
Client expense: $104,000 · Firm income: Not reported
2018 · third_quarter · Health Issues
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · second_quarter · Health Issues
Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; medical isotope production and supply.
Client expense: $380,000 · Firm income: Not reported
2018 · second_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and luxury cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills, tobacco regulation in the FDA
Client expense: $115,000 · Firm income: Not reported
2018 · second_quarter · Health Issues
Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) H.Res 827- Expressing Support for designation of April 2018 as "National Donate Life Month" Health equity and accountability Act of 2018(no bill # introduced 5/23) H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) Regulatory Accountability Act(S.951) S.Res479- A resolution designating April 2018 as "National Donate Life Month"
Client expense: $102,265 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · second_quarter · Health Issues
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · first_quarter · Health Issues
Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts, including the American Health Care Act, the Better Care Reconciliation Act, S 1835, the Lower Premiums Through Reinsurance Act of 2017, and the Graham/Cassidy amendment to the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention, including the Bipartisan Budget Act of 2018, HR 1892, and HR 1625, the Consolidated Appropriations Act of 2018; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; National Clinical Care Commission Act implementation; Senate price transparency workgroup; reduction/oversight of prior authorization and other administrative burdens; shared decision-making; disaster relief funding; medical isotope production and supply; tax reform legislation and related issues, including HR 1, the Tax Cuts and Jobs Act.
Client expense: $490,000 · Firm income: Not reported
2018 · first_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and luxury cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills
Client expense: $90,000 · Firm income: Not reported
2018 · first_quarter · Health Issues
American Health Care Act American Heart Month Resolution(S.Res.45) Better Reconciliation Act of 2017 Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Graham Cassidy H.Res.752-Recognizing the rise of cardiovascular disease as the world's leading cause of preventable death and disability and as the global public health crisis of our generation and recognizing February 2018 as "American Heart Month" H.R.3592 South Asian Heart Health Awareness and Research Act of 2017 H.R.1313, the Preserving Employer Wellness Programs Act Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951) S.Res.403-A resolution designating February 2018 as "American Heart Month" and February 2, 2018, as "National Wear Red Day" Tax Cuts and Jobs Act(H.R.1)(P.L.115-97)
Client expense: $45,380 · Firm income: Not reported
2018 · first_quarter · Health Issues
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · second_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267) Prohibit Smoking in VA Facilities Act (H.R.1662) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills
Client expense: $119,000 · Firm income: Not reported
2017 · second_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267) Prohibit Smoking in VA Facilities Act (H.R.1662) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills
Client expense: $119,000 · Firm income: Not reported
2017 · fourth_quarter · Health Issues
Organ Transplant Discrimination "Kevin and Avonte's Law (S. 2070/H.R. 4221) Congenital Heart Futures Act (S.477/H.R.1222)
Client expense: Not reported · Firm income: $10,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette and luxury cigar regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills
Client expense: $91,000 · Firm income: Not reported
2017 · fourth_quarter · Health Issues
American Health Care Act American Heart Month Resolution(S.Res.45) Better Reconciliation Act of 2017 CHAMPION Act(H.R.3922) Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Credit for Caring Act(S.1151) Graham Cassidy H.R.1313, the Preserving Employer Wellness Programs Act Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951) Tax Cuts and Jobs Act(H.R.1)(P.L.115-97)
Client expense: $40,713 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2017 · fourth_quarter · Health Issues
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 Patient Access to Care
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · fourth_quarter · Health Issues
Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace/reform efforts, including the American Health Care Act, the Better Care Reconciliation Act, S 1835, the Lower Premiums Through Reinsurance Act of 2017, and the Graham/Cassidy amendment to the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; FDA User Fee Program reauthorization; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention; HR 3592, the South Asian Heart Health Awareness and Research Act of 2017; research and scholarly communication policy, including S 1701/HR 3427, the Fair Access to Science and Technology Research Act of 2017; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309/S 920, the National Diabetes Clinical Care Commission Act; reduction of administrative burdens; disaster relief funding; medical isotope production and supply; tax reform legislation and related issues, including HR 1, the Tax Cuts and Jobs Act.
Client expense: $440,000 · Firm income: Not reported
2017 · third_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267/S.1301) Prohibit Smoking in VA Facilities Act (H.R.1662) The Veterans Affairs Medical Scribe Pilot Act of 2017 (H.R. 1848) Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills
Client expense: $109,000 · Firm income: Not reported
2017 · third_quarter · Health Issues
American Health Care Act American Heart Month Resolution(S.Res.45) Better Reconciliation Act of 2017 CHAMPION Act(H.R.3922) Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Credit for Caring Act(S.1151) Graham Cassidy Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951)
Client expense: $41,981 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2017 · third_quarter · Health Issues
Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace reform efforts, including the American Health Care Act, the Better Care Reconciliation Act and the Graham/Cassidy amendment to the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; FDA reauthorization; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309/S 920, the National Diabetes Clinical Care Commission Act; HR 3120, a bill to amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; reduction of administrative burdens; disaster relief funding.
Client expense: $730,000 · Firm income: Not reported
2017 · third_quarter · Health Issues
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 American Health Care Act, HR 1628 Better Care Reconciliation Act, HR 1628 Cassidy-Graham
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · second_quarter · Health Issues
American Health Care Act American Heart Month Resolution(S.Res.45/H.R.146) Better Reconciliation Act of 2017 Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Credit for Caring Act(S.1151) Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987) Regulatory Accountability Act(S.951)
Client expense: $142,995 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2017 · second_quarter · Health Issues
Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; Affordable Care Act repeal/replace reform efforts, including the American Health Care Act and the Better Care Reconciliation Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; unique device identifier policy and post-market surveillance for medical devices; FDA reauthorization; clinical trial design; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, the Prevention & Public Health Fund, medical research, and prevention; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309, the National Diabetes Clinical Care Commission Act.
Client expense: $430,000 · Firm income: Not reported
2017 · second_quarter · Health Issues
American Health Care Act of 2017 (HR 1628) Health Care Safety Net Enhancement Act (HR 548) Congenital Heart Futures Reauthorization Act (S 477/HR 1222) USPSTF Transparency and Accountability Act (HR 539) Protecting Access to Care Act of 2017 (HR 1215) Resident Physician Shortage Reduction Act of 2017 (HR2267) Prohibit Smoking in VA Facilities Act (H.R.1662) Medicare Access and CHIP Reauthorization Act of 2015 Implementation, Medicare Physician Payment Reform, MEDPAC, surgical global payments, Affordable Care Act Implementation, Affordable Care Act Repeal & Replace, health care reform, health care quality improvement, physician workforce, comparative effectiveness research, health information technology, EHR meaningful use, Patient-Centered Outcomes Research Institute, MEDCAC, Centers for Medicare & Medicaid Innovation, Medicare claims data, Social Security Death Master File, lung cancer screenings, AHRQ funding, USPSTF, Graduate Medical Education, electronic cigarette regulation, Physician-Focused Payment Model Technical Advisory Committee (PTAC), Proposed Medical Device Surveillance System, Meaningful Use, Congenital Heart Disease Funding, Unique Device Identifiers, Medical Liability Reform, essential health benefits, tobacco riders in appropriations bills
Client expense: $119,000 · Firm income: Not reported
2017 · second_quarter · Health Issues
Congenital Heart Futures Act Reauthorization; HR 1222, S 477 American Health Care Act, HR 1628 Better Care Reconciliation Act
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · first_quarter · Health Issues
American Health Care Act (H.R. 1628) Congenital Heart Futures Reauthorization Act (H.R. 1222/S. S. 477)
Client expense: Not reported · Firm income: $9,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Health Issues
American Health Care Act American Heart Month Resolution(S.Res.45/H.R.146) Common Sense Nutrition Disclosure Act(S.261/H.R.772) Congenital Heart Futures Reauthorization Act of 2017(H.R.1222/S.477) Menu Labeling(ACA Section 4205) Prevention and Public Health Fund(ACA Section 4002) Personal Health Investment Today Act(PHIT)(S.482/H.R.1267) RAISE Family Caregivers Act(S.354/H.R.987)
Client expense: $273,178 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2017 · first_quarter · Health Issues
Health care quality; physician and hospital quality; Patient Protection and Affordable Care Act/health care reform implementation; health care reform, including HR 1628, the American Health Care Act; medical liability reform, including HR 1215, the Protecting Access to Care Act; Physician Sunshine/Open Payments; informed consent and FDA-related research; unique device identifier policy and post-market surveillance for medical devices; Medical Device User Fee Act reauthorization; clinical data registries; the Common Rule and registries; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, HRSA, FDA, medical research, and prevention; healthy diet/lifestyle; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; S 477/HR 1222, the Congenital Heart Futures Reauthorization Act of 2017; HR 309, the National Diabetes Clinical Care Commission Act.
Client expense: $350,000 · Firm income: Not reported
2017 · first_quarter · Health Issues
Congenital Heart Futures Act Reauthorization; HR 1222, S 477
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1222.
Mr. Walden moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H10278-10280, H10313-10314)
Message on Senate action sent to the House.
Passed Senate with an amendment by Unanimous Consent.
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
The committee substitute withdrawn by Unanimous Consent. (CR S7525)
Measure laid before Senate by unanimous consent. (consideration: CR S7524-7525)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 555.
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 7 (Roll no. 81). (text: CR H1238-1239)
HousePassed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 394 - 7 (Roll no. 81).(text: CR H1238-1239)
HouseConsidered as unfinished business. (consideration: CR H1246-1247)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on H.R. 1222.
Considered under suspension of the rules. (consideration: CR H1238-1240)
Mr. Burgess moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 239.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-329.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Subcommittee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| House |
| Reported by |
| September 25, 2017 |
| Energy and Commerce Committee | House | Markup by | June 7, 2017 |
| Energy and Commerce Committee | House | Referred to | February 27, 2017 |
| February 27, 2018 |
| Engrossed in House | February 26, 2018 |
| Reported in House | September 25, 2017 |
| Introduced in House | February 27, 2017 |
| Enrolled Bill | -- |
| Republican |
| WA |
| Chris Collins | Republican | NY |
| Daniel Webster | Republican | FL |
| Darren Soto | Democratic | FL |
| David Loebsack | Democratic | IA |
| Dwight Evans | Democratic | PA |
| Eleanor Holmes Norton | Democratic | DC |
| Eric Swalwell | Democratic | CA |
| Gerald E. Connolly | Democratic | VA |
| H. Morgan Griffith | Republican | VA |
| Ileana Ros-Lehtinen | Republican | FL |
| Keith Ellison | Democratic | MN |
| Mark Pocan | Democratic | WI |
| Markwayne Mullin | Republican | OK |
| Mike Bost | Republican | IL |
| Nydia M. Velázquez | Democratic | NY |
| Patrick Meehan | Republican | PA |
| Pete Sessions | Republican | TX |
| Ralph Lee Abraham | Republican | LA |
| Richard M. Nolan | Democratic | MN |
| Seth Moulton | Democratic | MA |
| Stephanie N. Murphy | Democratic | FL |
| Steve Stivers | Republican | OH |
| Tim Walberg | Republican | MI |
| Tony Cárdenas | Democratic | CA |
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office